Guolian Group and Wuxi Venture Capital won many honors of "465" advanced collective and exemplary individual in the development of modern industrial clusters in Wuxi
On February 1st, in order to commend the relevant units and individuals who have made important contributions to the development of the "465" modern industrial cluster, further increase positive incentives, fully mobilize and stimulate the enthusiasm, initiative and creativity of various regions, departments, all sectors of society, and the general public to work and start businesses, the Wuxi Municipal Committee of the Communist Party of China and the Wuxi Municipal People's Government announced the list of advanced collectives and individuals in the development of the "465" modern industrial cluster in Wuxi. Guolian Group and Xichuang Capital have won multiple honors.
Guolian Group was awarded the title of Advanced Department
Xi Venture Capital was awarded the title of Excellent Service Institution
Several dozen partner enterprises of Xicheng Venture Capital have been honored with the "465" Advanced Collective Commendation List for the Development of Modern Industrial Clusters in Wuxi City
Wuxi Xuelang Numerical System Technology Co., Ltd
Wuxi Xingan Intelligent Semiconductor Co., Ltd
Jiangsu Longda Superalloy Co., Ltd
Wuxi Chelian Tianxia Information Technology Co., Ltd
AstraZeneca Pharmaceutical Co., Ltd
Wuxi Yaoming Biotechnology Co., Ltd
Jiangsu Zhiyuan Pharmaceutical Co., Ltd
Wuxi Times Angel Medical Equipment Technology Co., Ltd
Zhenhe Precision Medicine Laboratory Wuxi Co., Ltd
Wuxi Pioneer Intelligent Equipment Co., Ltd
Jiangsu Changdian Technology Co., Ltd
Jiangsu Yak Technology Co., Ltd
Xi Venture Capital actively responds to the spirit of the "Implementation Opinions on Accelerating the Construction of Key Industrial Clusters in Wuxi City to Build a '465' Modern Industrial Cluster" document. In 2023, it will establish multiple equity investment funds for high-quality development of listed companies, integrated circuits, new energy, biopharmaceuticals, and Xichuang Gongrong. The target size of the newly established funds will exceed 30 billion yuan, creating a '1+5+N' key industrial fund cluster, and the company will participate in managing a fund size of over 240 billion yuan. The company focuses on the construction of the "465" modern industrial cluster, deeply cultivating strategic emerging industries such as biomedicine, integrated circuits, dual carbon energy conservation, and advanced manufacturing. In 2023, it will add more than 100 investment projects with a total investment amount of nearly 10 billion yuan, promoting the listing of 8 enterprises including Xinan Technology, Xinhongye, and Jinghai Technology. At the same time, the company focuses on strengthening the chain, extending the chain, and supplementing the chain, exploring a new model of state-owned investment attraction with "investment leading and investment linkage", expanding supporting services for the industrial chain, and successively leading industrial projects such as United Aircraft and Xingan Technology to land in Wuxi, with a total landing amount of nearly 40 billion yuan, promoting the formation of industrial agglomeration effects and upstream downstream linkage effects.
Wang Zhixing, Co President of Wuxi Venture Capital, was awarded exemplary individual
Focusing on the construction of the "465" modern industrial cluster in Wuxi City, Wang Zhixing led the Wuxi Venture Capital investment team to complete over a hundred industrial equity investment projects in 2023, promoting the construction of a "1+5+N" industrial fund group for new energy, biomedicine, and other industries, with a total target size of over 30 billion yuan for newly established funds. He fully fulfilled the responsibilities of a member of the Wuxi Biomedical Industry Cluster Development Working Group, led the completion of a batch of biopharmaceutical project investments such as China Resources Biology, Jushu Biology, and Ruiyue Biology, and assisted in the completion of the Pan Son US stock privatization project; Focusing on leading companies in segmented fields, we have attracted dozens of biopharmaceutical projects such as Jianshi Medical through investment, with a total valuation of nearly 20 billion yuan. At the same time, adhering to the concept of "investing early, investing small, and investing in hard technology", with the guidance of the city's angel fund as the starting point, he led the completion of dozens of angel project investments and went deep into various sectors and regional incubators in Wuxi to serve high-quality startups, enrich the reserve of angel investment projects, and effectively support Wuxi's scientific and technological innovation and industrial development.
